Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38327
CAS Number:
251565-85-2
Tesaglitazar
Purity:
≥ 95% (HPLC)
Synonym(s):
(S)-2-Ethoxy-3-[4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phenyl]propanoicacid, (S)-2-Ethoxy-3-[4-[4-[(methylsulfonyl)oxy]phenethoxy]phenyl]propanoicacid
Documents
$363.84 /25MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Tesaglitazar is a novel dual PPAR (peroxisome proliferator-activated receptor) agonist, primarily recognized for its potential in the treatment of metabolic disorders such as type 2 diabetes and dyslipidemia. This compound exhibits unique properties that enable it to modulate glucose and lipid metabolism effectively, making it a valuable candidate in pharmaceutical research. Its dual action on PPARα and PPARγ pathways not only enhances insulin sensitivity but also promotes lipid metabolism, offering a comprehensive approach to managing metabolic syndrome.

Researchers and industry professionals can leverage Tesaglitazar in drug development aimed at addressing the growing prevalence of metabolic diseases. Its efficacy in improving glycemic control and lipid profiles positions it as a promising therapeutic agent. Additionally, Tesaglitazar's favorable safety profile and ability to target multiple metabolic pathways provide a competitive advantage over traditional single-target therapies, making it an attractive option for innovative treatment strategies in the pharmaceutical landscape.

Synonyms
(S)-2-Ethoxy-3-[4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phenyl]propanoicacid, (S)-2-Ethoxy-3-[4-[4-[(methylsulfonyl)oxy]phenethoxy]phenyl]propanoicacid
CAS Number
251565-85-2
Purity
≥ 95% (HPLC)
Molecular Formula
C20H24O7S
Molecular Weight
408.47
MDL Number
MFCD07784004
PubChem ID
11338777
Appearance
White to light yellow powder to crystal
Optical Rotation
-17 to -21 ° (C=1, AcOEt)
Conditions
Store at 2 - 8 °C
General Information
Synonyms
(S)-2-Ethoxy-3-[4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phenyl]propanoicacid, (S)-2-Ethoxy-3-[4-[4-[(methylsulfonyl)oxy]phenethoxy]phenyl]propanoicacid
CAS Number
251565-85-2
Purity
≥ 95% (HPLC)
Molecular Formula
C20H24O7S
Molecular Weight
408.47
MDL Number
MFCD07784004
PubChem ID
11338777
Appearance
White to light yellow powder to crystal
Optical Rotation
-17 to -21 ° (C=1, AcOEt)
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Tesaglitazar is widely utilized in research focused on

  • Diabetes Management: This compound has been studied for its potential in treating type 2 diabetes by improving insulin sensitivity and glucose metabolism, making it a valuable asset in diabetes research.
  • Cardiovascular Health: Tesaglitazar has shown promise in reducing cardiovascular risks associated with metabolic syndrome, which is crucial for developing therapies aimed at heart health.
  • Anti-inflammatory Applications: Its anti-inflammatory properties are being explored for conditions like arthritis, providing a potential alternative to traditional anti-inflammatory medications.
  • Drug Development: Researchers are investigating its unique mechanism of action for developing new drugs that target multiple pathways in metabolic diseases, offering a broader therapeutic approach.
  • Pharmaceutical Formulations: The compound's chemical stability and solubility make it suitable for various pharmaceutical formulations, enhancing the effectiveness of medications in clinical settings.

Citations